Bulletin 311 launched - Trimipramine

Trimipramine is a tricyclic antidepressant (TCA) that has been subject to significant price increases. Consequently, it does not represent a cost-effective choice of treatment.

This bulletin reviews the use of trimipramine with resources to support stopping or switching treatment in depression in adults.

Tools to support implementation include an audit tool, patient information, data and an educational slideset.

View >>